Search Results - "HEIDENREICH, Paul"

Refine Results
  1. 1
  2. 2
  3. 3

    Video-based AI for beat-to-beat assessment of cardiac function by Ouyang, David, He, Bryan, Ghorbani, Amirata, Yuan, Neal, Ebinger, Joseph, Langlotz, Curtis P., Heidenreich, Paul A., Harrington, Robert A., Liang, David H., Ashley, Euan A., Zou, James Y.

    Published in Nature (London) (01-04-2020)
    “…Accurate assessment of cardiac function is crucial for the diagnosis of cardiovascular disease 1 , screening for cardiotoxicity 2 and decisions regarding the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes by Shah, Kevin S, Xu, Haolin, Matsouaka, Roland A, Bhatt, Deepak L, Heidenreich, Paul A, Hernandez, Adrian F, Devore, Adam D, Yancy, Clyde W, Fonarow, Gregg C

    “…Patients with heart failure (HF) have a poor prognosis and are categorized by ejection fraction (EF). This study sought to characterize differences in outcomes…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    US Department of Justice Investigations of Implantable Cardioverter-Defibrillators and Quality Improvement in Health Care by Heidenreich, Paul A

    “…Heidenreich reflected on the investigations of implantable cardioverter-defibrillators (ICDs) and quality improvement in health care by the US Department of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review by McHugh, Kelly, DeVore, Adam D, Wu, Jingjing, Matsouaka, Roland A, Fonarow, Gregg C, Heidenreich, Paul A, Yancy, Clyde W, Green, Jennifer B, Altman, Natasha, Hernandez, Adrian F

    “…Heart failure with preserved ejection fraction (HFpEF) is now the most common form of HF, affecting over 3 million adults in the United States alone. HFpEF is…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Cost-effectiveness of Empagliflozin in Patients With Heart Failure With Preserved Ejection Fraction by Zheng, Jimmy, Parizo, Justin T, Spertus, John A, Heidenreich, Paul A, Sandhu, Alexander T

    Published in JAMA internal medicine (01-12-2022)
    “…In the Empagliflozin Outcome Trial in Patients With Chronic Heart Failure With Preserved Ejection Fraction (EMPEROR-Preserved), empagliflozin significantly…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20